Remove 2025 Remove Dosage Remove Packaging
article thumbnail

Sustainability continues to steer pharmaceutical packaging market

European Pharmaceutical Review

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.

article thumbnail

Six Biosimilars Part of EMA’s Authorization Recommendations in June

PharmTech

These approvals bring the total medicines approved for authorization in 2025 so far to 56. Meeting Highlights from the Committee for Medicinal Products for Human Use (CHMP) 16–19 June 2025. June 20, 2025. Ema.europa.eu (accessed June 23, 2025). Text sign showing Industry News. Press Release. Exceptional Circumstances.

Dosage 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BASF Opens GMP Manufacturing Facility in Michigan

PharmTech

Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. June 17, 2025. Press Release. Haigney, S.

Dosage 59
article thumbnail

FDA Issues Proposed Order to Facilitate Minor Changes to Solid Oral Dosage Forms to OTC Monograph Drugs, but Such Changes May Come at a Price

The FDA Law Blog

By Riëtte van Laack — On June 5, 2025, FDA announced two proposed monograph orders: 1) Proposed order OTC000038 proposes to make it easier to make (minor) changes to solid oral dosage forms not currently permitted under the specific order, and 2) proposed order OTC000037 proposes to require that certain oral dosage forms, namely orally disintegrating (..)

Dosage 59
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.

article thumbnail

FDA approves Widaplik for hypertension

The Checkup by Singlecare

The most common side effects of Widaplik include: Low blood sodium Low blood potassium Low blood pressure, which may cause dizziness The package insert cautions that taking non-steroidal anti-inflammatory drugs (NSAIDs) could lead to an increased risk of kidney problems and the possible loss of the medication’s antihypertensive effect.

FDA 66
article thumbnail

EIT Health Ireland–UK Expands European Network with Three New Members

PharmTech

European geopolitical shifts In two installments of Pharmaceutical Technology ®’s “Industry Outlook 2025” series, Alexander Seyf, CEO and co-founder of Autolomous, and Edwin Stone, CEO of Cellular Origins, discussed European political impacts on the pharmaceutical industry at large, and the pharma supply chain in particular. June 12, 2025.

Dosage 52